Search Results 11-20 of 8832 for Rivaroxaban
Rivaroxaban (Xarelto). Apixaban (Eliquis). Edoxaban (Savaysa). Heparin. These medicines must be taken exactly as directed to work safely and effectively ...
The purpose of this study is to evaluate the efficacy and safety of rivaroxaban compared with placebo in the prevention of symptomatic venous thromboembolism ( ...
Among the study's findings: Rivaroxaban showed no higher risk of bleeding in luminal gastrointestinal cancer and should not be considered contraindicated in ...
... rivaroxaban and apixaban). “We have strong data from large randomized clinical trials which demonstrate that the new medications are at least as good as ...
The purpose is to create a registry of patients at Mayo Clinic who are prescribed the new novel anticoagulation therapy with either rivaroxaban, dabigatran ...
... rivaroxaban compared to when using warfarin. One of the most common reasons people take anticoagulant medication – which lessens the blood's tendency to ...
The purpose of this study is to evaluate the effectiveness and safety of rivaroxaban compared with placebo in the prevention of symptomatic venous ...
... rivaroxaban). This medicine is to be given only by or under the supervision of your doctor or other health care professional. Back to top. Before Using. In ...
Advancements over medications such as warfarin, the standard anticoagulant for many years, with factor Xa inhibitors such as apixaban, rivaroxaban or ...
There wasn't a significant relationship between underdosing and the risks of stroke or bleeding for dabigatran or rivaroxaban users. “We conducted this study to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.